SCHEMBL7779782

SCHEMBL7779782

Cc1c(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccncc2)nn1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.49
LRRK2 Q5S007 5/20 0.47
CA2 P00918 5/20 0.47
CA1 P00915 4/20 0.47
CA9 Q16790 4/20 0.46
CA12 O43570 3/20 0.46
PTGS1 P23219 5/20 0.44
PTGS2 P35354 6/20 0.44
MT-CO2 P00403 1/20 0.44
LMNA P02545 1/20 0.44
CA3 P07451 1/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
ADRA2B P18089 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
SLC6A2 P23975 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777591 1.00 MAPK14 (0.49) MAPK14LRRK2CA2CA1CA9
SCHEMBL7779722 0.88 PTGS2 (0.50) MAPK14PTGS1PTGS2ALOX5
SCHEMBL7780877 0.88 PTGS2 (0.50) MAPK14PTGS1PTGS2ALOX5
SCHEMBL7779465 0.82 MAPK14 (0.45) MAPK14LRRK2CA2CA1CA9
SCHEMBL7777905 0.82 MAPK14 (0.48) MAPK14LRRK2CA2CA1CA9
SCHEMBL7773121 0.82 MAPK14 (0.45) MAPK14LRRK2CA2CA1CA9
SCHEMBL7773321 0.82 IKBKB (0.46) MAPK14LRRK2CA2CA1CA9
SCHEMBL7779780 0.82 IKBKB (0.46) MAPK14LRRK2CA2CA1CA9
SCHEMBL7780485 0.82 PTGS2 (0.58) MAPK14LRRK2CA2CA1CA9
SCHEMBL7779605 0.82 CA2 (0.46) MAPK14LRRK2CA2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed